SFCC Sfbc (MM)

SFBC International, Inc. (NASDAQ: SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, today announced that Jeffrey P. McMullen, chief executive officer of SFBC International, will present at the UBS Global Healthcare Services Conference at 1 p.m. ET on Monday, February 13, 2006. The conference will take place at The Grand Hyatt in New York City. All interested parties can access a live audio Webcast of the presentation through the "Webcasts" section of SFBC's Web site at www.sfbci.com. The replay of the Webcast will be available 3 hours after the actual presentation time, and will be available until March 15, 2006. About SFBC International, Inc. SFBC International, Inc. provides early and late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world. SFBC has more than 30 offices located in North America, Europe (including Central and Eastern Europe), South America, Asia, and Australia. In early clinical development services, SFBC specializes primarily in the areas of Phase I and early Phase II clinical trials and bioanalytical laboratory services, including early clinical pharmacology. SFBC also provides late stage clinical development services globally that focus on Phase II through IV clinical trials. SFBC also offers a range of complementary services, including data management and biostatistics, central laboratory services, medical and scientific affairs, regulatory affairs and submissions, and clinical IT solutions. Additional information is available on SFBC's website at www.sfbci.com.